Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1

被引:7
|
作者
Knak, Kirsten L. [1 ]
Sheikh, Aisha M. [1 ]
Andersen, Henning [2 ]
Witting, Nanna [1 ]
Vissing, John [1 ]
机构
[1] Rigshosp, Dept Neurol, Copenhagen, Denmark
[2] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark
关键词
MINIMAL DETECTABLE CHANGE; HAND-HELD DYNAMOMETER; TEST-RETEST RELIABILITY; EXTENSOR STRENGTH; STANDING BALANCE; TESTS; PEOPLE; HIP; GO; ASSESSMENTS;
D O I
10.1212/WNL.0000000000009625
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate intrarater reliability and concurrent and construct validity of muscle strength, balance, and functional mobility measures in individuals with noncongenital myotonic dystrophy type 1 (DM1). Methods Seventy-eight adults with noncongenital DM1 participated in visit 1, and 73 of the them participated in visit 2 separated by 1 to 2 weeks. The assessments consisted of muscle strength tests with handheld dynamometry (HHD) and stationary dynamometry in the lower limb. The balance tests consisted of the step test, Timed Up and Go test, feet-together stance, tandem stance, 1-leg stance, and modified Clinical Test of Sensory Integration and Balance on a balance platform. The functional mobility tests consisted of the 10-m walk test (10mWT) and 10-times Sit-to-Stand test. Results The HHD and stationary dynamometry had sufficient intrarater reliability for most muscle groups on a group (SEM%<= 15%) and individual (minimal detectable difference [MDD95%] <= 30%) level, but the HHD was most reliable. Stationary dynamometry measured a higher torque than HHD for all extensor muscles, but for single individuals, none of the devices were favored. Overall, intrarater reliability and validity were sufficient only for the dynamic balance tests, not the static balance tests. Both functional mobility tests were sufficiently reliable and valid, but the 10mWT was most reliable. Conclusion Overall, HHD is recommended as a reliable and valid tool for single individuals and for flexor muscles on a group level. For balance assessments, the dynamic balance tests are recommended as the most valid and reliable balance tests. Both functional mobility tests are recommended for valid and reliable outcomes, but the 10mWT was superior for reliability.
引用
收藏
页码:E2508 / E2520
页数:13
相关论文
共 50 条
  • [1] Responsiveness of outcome measures in myotonic dystrophy type 1
    Knak, Kirsten L.
    Sheikh, Aisha M.
    Witting, Nanna
    Vissing, John
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (08): : 1382 - 1391
  • [2] Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?
    Fortin, Julie
    Cote, Isabelle
    Gagnon, Cynthia
    Gallais, Benjamin
    NEUROMUSCULAR DISORDERS, 2023, 33 (06) : 490 - 497
  • [3] Reliability of balance, function, and muscle strength measures in myotonic dystrophy type 1
    Knak, K.
    Sheikh, A.
    Andersen, H.
    Witting, N.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S50 - S50
  • [4] Body composition and clinical outcome measures in patients with myotonic dystrophy type 1
    Sedehizadeh, Saam
    Brook, J. David
    Maddison, Paul
    NEUROMUSCULAR DISORDERS, 2017, 27 (03) : 286 - 289
  • [5] Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
    Montagnese, Federica
    Rastelli, Emanuele
    Khizanishvili, Nina
    Massa, Roberto
    Stahl, Kristina
    Schoser, Benedikt
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [6] Patient reported outcome measures in myotonic dystrophy type 2
    Montagnese, F.
    Rastelli, E.
    Stahl, K.
    Khizanishvili, N.
    Schoser, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 250 - 250
  • [7] Patient reported outcome measures in myotonic dystrophy type 2
    Montagnese, F.
    Rastelli, E.
    Stahl, K.
    Khizanishvili, N.
    Schoser, B.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S49 - S50
  • [8] Validation of motor specific outcome measures in myotonic dystrophy type 2
    Rastelli, E.
    Montagnese, F.
    Stahl, K.
    Massa, R.
    Schoser, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 693 - 693
  • [9] REVIEW OF PATIENT-REPORTED OUTCOME MEASURES FOR USE IN MYOTONIC DYSTROPHY TYPE 1 PATIENTS
    Symonds, Tara
    Randall, Jason A.
    Campbell, Patrick
    MUSCLE & NERVE, 2017, 56 (01) : 86 - 92
  • [10] Responsiveness of outcome measures in myotonic dystrophy type 1 (vol 7, pg 1382, 2020)
    Knak, K. L.
    Sheikh, A. M.
    Witting, N.
    Vissing, J.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (10): : 2105 - 2105